- Udyam number
- UDYAM-DL-09-0007107

About Pharmazz India Private Limited
Data last updated:
Pharmazz India Private Limited is a foreign private limited company based in New Delhi, Delhi, India, a subsidiary of Pharmazz Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2011FTC215954. Its GSTIN is 07AAFCP9131M1Z1 (Delhi). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.81 Cr. It is led by directors including Manish Subhashrao Lavhale (Managing Director) and Anil Gulati.
Its last annual general meeting (AGM) was held on 10 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No.4 Pocket B Sarita Vihar, New Delhi, Delhi, India – 110076.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.18 Cr, a growth of 138% compared to the previous year. For the same year it recorded a net profit of ₹3.53 Cr (net margin 19.4%) and EBITDA of ₹8.03 Cr (EBITDA margin 44.2%). Revenue has grown at a compounded annual rate (CAGR) of 257% over three years and 195% over five years.
The company has about 37 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pharmazz. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Pharmazz India Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-DL-09-0007107). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmazz.com.
Recognitions & Rankings of Pharmazz India
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressFlat No.4 Pocket B Sarita Vihar, New Delhi, Delhi, India – 110076
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Pharmazz India Private Limited
Pharmazz India operates one associated brand: Pharmazz. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Clinical stage company developing critical care medicines | pharmazz.com |
Business Activity of Pharmazz India Private Limited
The main business activities of Pharmazz India are trade and professional, scientific and technical. In detail, this covers wholesale trading and scientific research and development. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pharmazz India Private Limited FY 2024 filings available
Pharmazz India Private Limited reported revenue of ₹18.18 Cr (up 138% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Pharmazz India Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 195% over five years, including 138% growth in the latest year. EBITDA rose 115% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharmazz India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.03 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.53 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharmazz India Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 19.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharmazz India are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Pharmazz India Private Limited
Pharmazz India has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Gulati | Director | 16 Mar 2011 | 15 Years 7 Months | Current |
| Sunil Gulati | Director | 16 Mar 2011 | 15 Years 7 Months | Current |
| Lov Verma | Director | 04 Feb 2017 | 9 Years 8 Months | Current |
| Manish Subhashrao Lavhale | Managing Director | 14 Aug 2021 | 5 Years 2 Months | Current |
| Dharmesh Kiritkumar Shah | Additional Director | 24 Nov 2025 | 0 Years 10 Months | Current |
Peer Comparison of Pharmazz India Private Limited
Pharmazz India Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vipragen Biosciences Private Limited | ₹18.35 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Mysore, Karnataka, India |
| Aryan Biotech Private Limited | ₹18.29 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Uttranchal, Uttar Pradesh, India |
| Artemis Properties Private Limited | ₹18.24 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Bharuch, Gujarat, India |
| Oplos Medicare Pharmaceuticals Private Limited | ₹18.23 Cr (FY 2019) | •••• | •••• | 54.0% | •••• | Delhi, India |
| Vivancemed India Private Limited | ₹18.19 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Bangalore, Karnataka, India |
| Pharmazz India Private Limited this company | ₹18.18 Cr (FY 2024) | •••• | •••• | 138.0% | •••• | New Delhi, Delhi, India |
| Monolom India Pharma Private Limited | ₹18.17 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Pune, Maharashtra, India |
| Rashmi Pharma Private Limited | ₹18.17 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Telangana, India |
| Shape Pharma Private Limited | ₹18.17 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Surendranagar, Gujarat, India |
| Spazio Formulations Limited | ₹18.17 Cr (FY 2023) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Zaneka Healthcare Limited | ₹18.16 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Haridwar, Uttarakhand, India |
Peers are the five companies nearest above and the five nearest below Pharmazz India by revenue in the Pharma industry (Contract Research, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pharmazz India Private Limited
Pharmazz India Private Limited is audited by S. BAJAJ & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S. BAJAJ & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Pharmazz India Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharmazz India Private Limited
Pharmazz India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Pharmazz India Private Limited
Pharmazz India Private Limited has 2 court cases on record: 2 filed by Pharmazz India. 1 case is pending and 1 is disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed by the company against Fortis Clinical Research Limited | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against Union of India & Ors | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Pharmazz India Private Limited
Pharmazz India Private Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 67 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ontime Globe Kyarrier Pvt Ltd | •••• | •••• | •••• |
| S Bajaj & Associates | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Newtronic Lifecare Equipment Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 12 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Pharmazz India Private Limited
Pharmazz India Private Limited has a workforce of 37 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmazz India Private Limited
Pharmazz India Private Limited has 11 board changes on record since 2011: 5 appointments and 6 cessations. The latest: Dharmesh Kiritkumar Shah was appointed as Additional Director on 24 Nov 2025.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Pharmazz India Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmazz India Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmazz India Private Limited
Pharmazz India has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCP9131M1Z1 | Delhi | Active | 15 Oct 2020 |
| 09AAFCP9131M1ZX | Uttar Pradesh | Active | 01 Jul 2017 |
| 24AAFCP9131M1Z5 | Gujarat | Active | 16 Dec 2020 |
| 34AAFCP9131M1Z4 | Puducherry | Active | 22 Dec 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmazz India Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Pharmazz India Private Limited
Frequently Asked Questions about Pharmazz India Private Limited
Pharmazz India is an active foreign private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2011 (15+ years old) and is registered under CIN U24100DL2011FTC215954.
Pharmazz India reported revenue of ₹18.18 Cr for FY 2024 (up 138% YoY).
Pharmazz India has 5 current directors:
- Manish Subhashrao Lavhale - Managing Director
- Anil Gulati - Director
- Sunil Gulati - Director
- Lov Verma - Director
- Dharmesh Kiritkumar Shah - Additional Director
Pharmazz India reported a net profit of ₹3.53 Cr (net margin 19.4%) and EBITDA of ₹8.03 Cr (EBITDA margin 44.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharmazz India is 257% over three years and 195% over five years. In the latest year (FY 2024) revenue rose 138%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharmazz India is 07AAFCP9131M1Z1, registered in Delhi. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 09AAFCP9131M1ZX (Uttar Pradesh), 24AAFCP9131M1Z5 (Gujarat), 34AAFCP9131M1Z4 (Puducherry).
The CIN (Corporate Identification Number) of Pharmazz India is U24100DL2011FTC215954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmazz India has 2 court cases on record: 2 filed by the company. 1 is pending. Most are in the high courts.
Pharmazz India was incorporated on 16 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Pharmazz India by revenue are Vipragen Biosciences Private Limited, Aryan Biotech Private Limited, Artemis Properties Private Limited, Oplos Medicare Pharmaceuticals Private Limited, Vivancemed India Private Limited and 5 more, all in the Pharma industry (Contract Research, Formulations).
Dharmesh Kiritkumar Shah was appointed as Additional Director on 24 Nov 2025. Manish Subhashrao Lavhale ceased to be Whole-Time Director on 23 Nov 2022. Sunil Gulati ceased to be Whole-Time Director on 23 Nov 2022. Pharmazz India has 11 board changes on record in total.
Yes, Pharmazz India is registered as an MSME under Udyam registration (number: UDYAM-DL-09-0007107).